AGL 40.00 Decreased By ▼ -0.21 (-0.52%)
AIRLINK 127.00 Decreased By ▼ -0.64 (-0.5%)
BOP 6.72 Increased By ▲ 0.05 (0.75%)
CNERGY 4.51 Increased By ▲ 0.06 (1.35%)
DCL 8.65 Decreased By ▼ -0.08 (-0.92%)
DFML 41.10 Decreased By ▼ -0.06 (-0.15%)
DGKC 85.40 Decreased By ▼ -0.71 (-0.82%)
FCCL 33.10 Increased By ▲ 0.54 (1.66%)
FFBL 65.77 Increased By ▲ 1.39 (2.16%)
FFL 11.65 Increased By ▲ 0.04 (0.34%)
HUBC 111.47 Decreased By ▼ -0.99 (-0.88%)
HUMNL 14.74 Decreased By ▼ -0.07 (-0.47%)
KEL 5.16 Increased By ▲ 0.12 (2.38%)
KOSM 7.59 Increased By ▲ 0.23 (3.13%)
MLCF 40.35 Increased By ▲ 0.02 (0.05%)
NBP 60.11 Decreased By ▼ -0.97 (-1.59%)
OGDC 194.25 Increased By ▲ 0.07 (0.04%)
PAEL 26.60 Decreased By ▼ -0.31 (-1.15%)
PIBTL 7.38 Increased By ▲ 0.10 (1.37%)
PPL 153.80 Increased By ▲ 1.12 (0.73%)
PRL 26.20 Decreased By ▼ -0.02 (-0.08%)
PTC 17.11 Increased By ▲ 0.97 (6.01%)
SEARL 85.60 Decreased By ▼ -0.10 (-0.12%)
TELE 7.58 Decreased By ▼ -0.09 (-1.17%)
TOMCL 34.50 Decreased By ▼ -1.97 (-5.4%)
TPLP 8.93 Increased By ▲ 0.14 (1.59%)
TREET 16.80 Decreased By ▼ -0.04 (-0.24%)
TRG 62.55 Decreased By ▼ -0.19 (-0.3%)
UNITY 27.25 Decreased By ▼ -0.95 (-3.37%)
WTL 1.30 Decreased By ▼ -0.04 (-2.99%)
BR100 10,113 Increased By 27.5 (0.27%)
BR30 31,179 Increased By 9.1 (0.03%)
KSE100 94,996 Increased By 232 (0.24%)
KSE30 29,481 Increased By 71 (0.24%)
Pakistan

Novartis donates RS41.25mn to PRCS for the fight against COVID-19 pandemic

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas m
Published May 7, 2020
  • Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Novartis donated PKR 41.25 Million to Pakistan Red Crescent Society (PRCS), one of the largest humanitarian organizations in the country to support in efforts against COVID-19.

Novartis Pakistan will be working with PRCS to distribute the Testing Kits and PPEs to Health Care staff in areas most severely affected across all provinces.

Dr. Imran Rasheed, Chief Executive Officer, Novartis Pharma Pakistan, said, “Novartis Pakistan feels proud to stand with our Healthcare Professionals at their hour of need and hope to mitigate and contain this deadly infection as soon as humanly possible. Novartis has always remained on the forefront when it comes to Corporate Social Responsibility.

In Pakistan, we have ongoing projects in collaboration with government, NGOs and other partners working actively for the benefits of patients. We have the biggest Oncology Access program in Pakistan, providing cancer medicines free of cost, worth billions of rupees. During this challenging time of COVID-19 Pandemic, with this donation, Novartis contributing back to the society is core to our strategy and one of the pillars of Novartis vision”.

Comments

Comments are closed.